Anti Type IV Collagen (raised against mouse) pAb (Rabbit, Antiserum)

Catalog No:
LSL-LB-1403
$468.00

Click here to browse a well organized list of products for Bone, Collagen, and Extracellular Matrix research.

Click here for more Allergen-related products

Application: ELISA, IF, WB, IHC(f), IHC(p) 
Clonality: Polyclonal 
Host: Rabbit 
Purification: Serum 
Reactivity: Guinea Pig, Mink, Mouse, Rat, Bovine 
Documents & Links for Anti Type IV Collagen (raised against mouse) pAb (Rabbit, Antiserum)
Datasheet lsl-lb-1403_anti-collagen-4-pab-mouse_datasheet.pdf

Documents & Links for Anti Type IV Collagen (raised against mouse) pAb (Rabbit, Antiserum)
Datasheet lsl-lb-1403_anti-collagen-4-pab-mouse_datasheet.pdf

Citations for Anti Type IV Collagen (raised against mouse) pAb (Rabbit, Antiserum) – 19 Found
Tay et al. 2019. Halted Lymphocyte Egress via Efferent Lymph Contributes to Lymph Node Hypertrophy During Hypercholesterolemia. Front Immunol. 10(575):.   PubMed, Journal
Vollert et al. 2015. Formaldehyde scavengers function as novel antigen retrieval agents. Sci Rep. 5:17322.   PubMed, Journal
Yang et al. 2015. Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis. EMBO Mol Med. 7(10):1267-84.   PubMed, Journal
Kangsamaksin et al. 2015. NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth. Cancer Discov. 5(2):182-97.   PubMed, Journal
Dong et al. 2011. Vascular cell-adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress. PNAs. 108(35):14614-9.   PubMed, Journal
Kubota et al. 2011. Isolation and function of mouse tissue resident vascular precursors marked by myelin protein zero. J Exp Med. 208(5):949-60.   PubMed, Journal
Yu et al. 2011. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med. 3(84):84ra44.   PubMed, Journal
Okuno et al. 2011. Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healing. Blood. 117(19):5264-72.   PubMed, Journal
Ito et al. 2011. Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum. J Neurol Neurosurg Psychiatry. 82(3):294-9.   PubMed, Journal
Hofmann et al. 2010. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome. Development. 137(23):4061-72.   PubMed, Journal
Coxon et al. 2010. Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody. Mol Cancer Ther. 9(10):2641-51.   PubMed, Journal
Davies et al. 2010. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab. 12(1):42-52.   PubMed, Journal
Kurihara et al. 2010. von Hippel-Lindau protein regulates transition from the fetal to the adult circulatory system in retina. Development. 137(9):1563-71.   PubMed, Journal
Yamashita et al. 2009. Establishment of a standardized post-embedding method for immunoelectron microscopy by applying heat-induced antigen retrieval. J Electron Microsc (Tokyo). 58(4):267-79.   PubMed, Journal
Saito et al. 2009. Tissue factor and factor v involvement in rat peritoneal fibrosis. Perit Dial Int. 29(3):340-51.   PubMed, Journal
Norrmén et al. 2009. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol. 185(3):439-57.   PubMed, Journal
Kubota et al. 2009. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med. 206(5):1089-102.   PubMed, Journal
Chang et al. 2009. VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res. 69(10):4537-44.   PubMed, Journal
Crawford et al. 2009. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell. 15(1):21-34.   PubMed, Journal